Real Estate -
REIT - Healthcare Facilities - NASDAQ - US
$ 16.94
-1.4 %
$ 4.01 B
Market Cap
41.32
P/E
1. INTRINSIC VALUE
Balance Sheet
Sabra Health Care REIT, Inc.
| Current Assets | 213 M |
| Cash & Short-Term Investments | 41.3 M |
| Receivables | 103 M |
| Other Current Assets | 68.1 M |
| Non-Current Assets | 4.84 B |
| Long-Term Investments | 195 M |
| PP&E | 0 |
| Other Non-Current Assets | 4.65 B |
| Current Liabilities | 231 M |
| Accounts Payable | 73.8 M |
| Short-Term Debt | 96.5 M |
| Other Current Liabilities | 61.2 M |
| Non-Current Liabilities | 2.35 B |
| Long-Term Debt | 2.35 B |
| Other Non-Current Liabilities | 0 |
EFFICIENCY
Earnings Waterfall
Sabra Health Care REIT, Inc.
| Revenue | 648 M |
| Cost Of Revenue | 378 M |
| Gross Profit | 269 M |
| Operating Expenses | 42.4 M |
| Operating Income | 222 M |
| Other Expenses | 208 M |
| Net Income | 13.8 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Sabra Health Care REIT, Inc.
| Net Income | 13.8 M |
| Depreciation & Amortization | 183 M |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 7.92 M |
| Change in Working Capital | -2.73 M |
| Others | 87.5 M |
| Free Cash Flow | 301 M |
Wall Street Analysts Price Targets
Sabra Health Care REIT, Inc.
Wall Street analysts predict an average 1-year price target for SBRA of $17.2 , with forecasts ranging from
a
low of
$15 to a high of $20 .
SBRA Lowest Price Target
Wall Street Target
15 USD
-11.45%
SBRA Average Price Target
Wall Street Target
17.2 USD
1.83%
SBRA Highest Price Target
Wall Street Target
20 USD
18.06%
4. DIVIDEND
ANALYSIS
1.61%
DIVIDEND YIELD
0.3 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Sabra Health Care REIT, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
147 K USD 1
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
101 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
7 months ago
May 22, 2024
|
Bought
101 K USD
|
Cusack Catherine
Director
|
+ 7000
|
14.43 USD |
|
8 months ago
May 14, 2024
|
Sell 147 K
USD
|
FOSTER MICHAEL J
Director
|
- 10000
|
14.683 USD |
|
1 year ago
Sep 01, 2023
|
Bought
24.6 K USD
|
Costa Michael Lourenco
Executive VP, CFO & Secretary
|
+ 1947
|
12.63 USD |
|
2 years ago
Feb 25, 2022
|
Bought
26.5 K USD
|
Cusack Catherine
Director
|
+ 2000
|
13.24 USD |
|
3 years ago
Dec 29, 2021
|
Sell 1.49 M
USD
|
Andrews Harold W. Jr.
Executive VP, CFO & Secretary
|
- 110000
|
13.5522 USD |
|
3 years ago
May 13, 2021
|
Bought
34.4 K USD
|
Cusack Catherine
Director
|
+ 2000
|
17.19 USD |
|
3 years ago
Mar 04, 2021
|
Sell 52.2 K
USD
|
FOSTER MICHAEL J
Director
|
- 3000
|
17.39 USD |
|
3 years ago
Mar 04, 2021
|
Sell 52.4 K
USD
|
FOSTER MICHAEL J
Director
|
- 3000
|
17.48 USD |
|
3 years ago
Mar 02, 2021
|
Bought
17.3 K USD
|
Cusack Catherine
Director
|
+ 1000
|
17.34 USD |
|
4 years ago
Mar 06, 2020
|
Sell 194 K
USD
|
Ettl Robert A.
Director
|
- 10545
|
18.3896 USD |
|
4 years ago
Mar 16, 2020
|
Bought
24.8 K USD
|
FOSTER MICHAEL J
Director
|
+ 3200
|
7.75 USD |
|
4 years ago
Mar 16, 2020
|
Bought
74.6 K USD
|
FOSTER MICHAEL J
Director
|
+ 9675
|
7.7136 USD |
|
5 years ago
Nov 04, 2019
|
Sell 2.72 M
USD
|
MATROS RICHARD K
Chairman, CEO and President
|
- 113000
|
24.0467 USD |
|
5 years ago
Aug 26, 2019
|
Sell 1.25 M
USD
|
Lewis Raymond J
Director
|
- 58000
|
21.4743 USD |
|
5 years ago
Aug 14, 2019
|
Sell 312 K
USD
|
FOSTER MICHAEL J
Director
|
- 15000
|
20.78 USD |
|
6 years ago
Mar 22, 2018
|
Sell 10.4 K
USD
|
Andrews Harold W. Jr.
Executive VP, CFO & Secretary
|
- 600
|
17.36 USD |
|
7 years ago
Nov 30, 2017
|
Sell 88.5 K
USD
|
WALTERS MILTON J
Director
|
- 4615
|
19.1795 USD |
|
8 years ago
Jun 06, 2016
|
Sell 44.1 K
USD
|
WALTERS MILTON J
Director
|
- 2000
|
22.04 USD |
|
9 years ago
Dec 08, 2015
|
Bought
99.3 K USD
|
FOSTER MICHAEL J
Director
|
+ 5000
|
19.8581 USD |
|
9 years ago
Nov 13, 2015
|
Sell 49.4 K
USD
|
WALTERS MILTON J
Director
|
- 2500
|
19.75 USD |
|
9 years ago
Nov 13, 2015
|
Bought
49.5 K USD
|
WALTERS MILTON J
Director
|
+ 2500
|
19.8 USD |
|
9 years ago
Nov 12, 2015
|
Bought
126 K USD
|
Andrews Harold W. Jr.
Executive VP, CFO & Secretary
|
+ 6600
|
19.0707 USD |
|
9 years ago
Jun 15, 2015
|
Bought
51 K USD
|
Ettl Robert A.
Director
|
+ 2000
|
25.49 USD |
|
9 years ago
Jun 09, 2015
|
Bought
17.6 K USD
|
FOSTER MICHAEL J
Director
|
+ 697
|
25.29 USD |
|
9 years ago
Jun 09, 2015
|
Bought
111 K USD
|
FOSTER MICHAEL J
Director
|
+ 4377
|
25.29 USD |
|
9 years ago
May 07, 2015
|
Bought
97.8 K USD
|
Ettl Robert A.
Director
|
+ 3500
|
27.95 USD |
|
9 years ago
Feb 20, 2015
|
Sell 81.2 K
USD
|
WALTERS MILTON J
Director
|
- 2500
|
32.4924 USD |
|
9 years ago
Feb 20, 2015
|
Bought
81.3 K USD
|
WALTERS MILTON J
Director
|
+ 2500
|
32.5157 USD |
|
11 years ago
Aug 14, 2013
|
Bought
99.7 K USD
|
FOSTER MICHAEL J
Director
|
+ 4000
|
24.9296 USD |
|
11 years ago
Aug 14, 2013
|
Bought
101 K USD
|
Nevo-Hacohen Talya
Executive VP, CIO & Treasurer
|
+ 4000
|
25.2422 USD |
|
11 years ago
Aug 13, 2013
|
Bought
20.2 K USD
|
Andrews Harold W. Jr.
Executive VP, CFO & Secretary
|
+ 800
|
25.21 USD |
|
11 years ago
Aug 09, 2013
|
Bought
25 K USD
|
Barbarosh Craig A.
Director
|
+ 1000
|
24.989 USD |
|
11 years ago
Aug 09, 2013
|
Bought
100 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 4000
|
25.0295 USD |
|
11 years ago
May 30, 2013
|
Bought
55.6 K USD
|
Ettl Robert A.
Director
|
+ 2000
|
27.8 USD |
|
11 years ago
Mar 21, 2013
|
Sell 83.4 K
USD
|
WALTERS MILTON J
Director
|
- 3000
|
27.796 USD |
|
13 years ago
Nov 23, 2011
|
Bought
9.99 K USD
|
Barbarosh Craig A.
Director
|
+ 1000
|
9.99 USD |
|
13 years ago
Nov 09, 2011
|
Bought
55 K USD
|
FOSTER MICHAEL J
Director
|
+ 5000
|
10.9932 USD |
|
13 years ago
Aug 12, 2011
|
Bought
28.1 K USD
|
WALTERS MILTON J
Director
|
+ 2500
|
11.2369 USD |
|
13 years ago
Aug 11, 2011
|
Bought
11 K USD
|
Barbarosh Craig A.
Director
|
+ 1000
|
11.023 USD |
|
13 years ago
Aug 09, 2011
|
Bought
53.2 K USD
|
FOSTER MICHAEL J
Director
|
+ 5000
|
10.6353 USD |
|
13 years ago
Aug 08, 2011
|
Bought
49.7 K USD
|
Ettl Robert A.
Director
|
+ 4500
|
11.05 USD |
|
13 years ago
Aug 08, 2011
|
Bought
10.8 K USD
|
Barbarosh Craig A.
Director
|
+ 1000
|
10.79 USD |
|
13 years ago
Aug 08, 2011
|
Bought
44.7 K USD
|
Nevo-Hacohen Talya
Executive VP, CIO & Treasurer
|
+ 4000
|
11.18 USD |
|
13 years ago
Aug 08, 2011
|
Bought
29.5 K USD
|
Andrews Harold W. Jr.
Executive VP, CFO & Secretary
|
+ 2650
|
11.14 USD |
|
13 years ago
Aug 08, 2011
|
Bought
2.23 K USD
|
Andrews Harold W. Jr.
Executive VP, CFO & Secretary
|
+ 200
|
11.13 USD |
|
13 years ago
Aug 08, 2011
|
Bought
7.78 K USD
|
Andrews Harold W. Jr.
Executive VP, CFO & Secretary
|
+ 700
|
11.12 USD |
|
13 years ago
Aug 08, 2011
|
Bought
10.6 K USD
|
Andrews Harold W. Jr.
Executive VP, CFO & Secretary
|
+ 950
|
11.11 USD |
|
13 years ago
Aug 08, 2011
|
Bought
11.5 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 1000
|
11.46 USD |
|
13 years ago
Aug 08, 2011
|
Bought
2.29 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 200
|
11.45 USD |
|
13 years ago
Aug 08, 2011
|
Bought
1.14 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 100
|
11.44 USD |
|
13 years ago
Aug 08, 2011
|
Bought
9.14 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 800
|
11.43 USD |
|
13 years ago
Aug 08, 2011
|
Bought
1.14 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 100
|
11.42 USD |
|
13 years ago
Aug 08, 2011
|
Bought
4.56 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 400
|
11.41 USD |
|
13 years ago
Aug 08, 2011
|
Bought
1.14 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 100
|
11.4 USD |
|
13 years ago
Aug 08, 2011
|
Bought
14.8 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 1300
|
11.36 USD |
|
13 years ago
Aug 08, 2011
|
Bought
6.76 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 596
|
11.35 USD |
|
13 years ago
Aug 08, 2011
|
Bought
1.13 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 100
|
11.34 USD |
|
13 years ago
Aug 08, 2011
|
Bought
9.78 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 863
|
11.33 USD |
|
13 years ago
Aug 08, 2011
|
Bought
7.92 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 700
|
11.32 USD |
|
13 years ago
Aug 08, 2011
|
Bought
13.9 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 1227
|
11.31 USD |
|
13 years ago
Aug 08, 2011
|
Bought
4.68 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 414
|
11.3 USD |
|
13 years ago
Aug 08, 2011
|
Bought
5.64 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 500
|
11.29 USD |
|
13 years ago
Aug 08, 2011
|
Bought
2.26 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 200
|
11.28 USD |
|
13 years ago
Aug 08, 2011
|
Bought
1.13 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 100
|
11.27 USD |
|
13 years ago
Aug 08, 2011
|
Bought
1.13 K USD
|
MATROS RICHARD K
Chairman, CEO and President
|
+ 100
|
11.26 USD |
7. News
Sabra Health Care REIT: Buy Into Future Demand For Skilled Nursing Facilities
Sabra Health Care REIT gets rated buy, agreeing with consensus, and driven heavily by macro-level demand forecasts for skilled nursing facilities. The stock is undervalued on forward P/FFO vs key peers, and is trading close to its moving average now. The firm has investment-grade ratings from Fitch and Moody's agencies.
seekingalpha.com
- 2 weeks ago
Sabra Health Care REIT: A High-Yielding Gift Just In Time For The New Year
With the FED's rate cut predictions for 2025, Sabra Health Care REIT offers a buying opportunity for long-term investors, especially retirees and income investors. Sabra's solid fundamentals, including improved occupancy rates and a safe 6% dividend yield, make it an attractive investment despite recent market sell-offs. The REIT's balance sheet has strengthened, with Moody's upgrading their outlook to positive, indicating potential for future investment opportunities and price appreciation.
seekingalpha.com
- 2 weeks ago
Sabra (SBRA) Upgraded to Buy: Here's Why
Sabra (SBRA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zacks.com
- 3 weeks ago
Sabra Health Care REIT: A Promising Value Play In Healthcare Real Estate
Sabra Health Care REIT offers a compelling investment opportunity with a reasonable valuation, trading at 13.6x 2024 FFO and 12.9x 2025 FFO. The company benefits from strong industry fundamentals, including an aging population and growing demand for senior living and healthcare facilities. Q3'24 results showed robust performance with occupancy gains and NOI growth, particularly in the SHOP portfolio, indicating effective operational leverage.
seekingalpha.com
- 1 month ago
Sabra Health Care REIT, Inc. to Attend Nareit's REITworld 2024 Annual Conference
TUSTIN, Calif.--(BUSINESS WIRE)-- #REITworld--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Senior Vice President of Finance, will attend Nareit's REITworld 2024 Annual Conference on November 19-20, 2024 at the Wynn Las Vegas in Las Vegas, Nevada. About Sabra Sabra Health C.
businesswire.com
- 2 months ago
Sabra Health Care REIT, Inc. (SBRA) Q3 2024 Earnings Call Transcript
Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q3 2024 Earnings Conference Call November 1, 2024 1:00 PM ET Company Participants Lukas Hartwich - Senior Vice President, Finance Rick Matros - Chief Executive Officer, President & Chair of the Board Talya Nevo-Hacohen - Chief Investment Officer, Treasurer & Executive Vice President Michael Costa - Chief Financial Officer Conference Call Participants Elmer Chang - Scotiabank John Kilichowski - Wells Fargo Austin Wurschmidt - KeyBanc Juan Sanabria - BMO Capital Michael Griffin - Citi Rich Anderson - Wedbush Alec Feygin - Baird Michael Stroyeck - Green Street Omotayo Okusanya - Deutsche Bank Operator Good day, everyone. My name is Adam, and I will be your conference operator today.
seekingalpha.com
- 2 months ago
Sabra (SBRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zacks.com
- 2 months ago
Sabra Healthcare (SBRA) Q3 FFO and Revenues Surpass Estimates
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.37 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to FFO of $0.34 per share a year ago.
zacks.com
- 2 months ago
Moody's Upgrades Sabra Health Care REIT, Inc.'s Outlook to Positive, Affirms Credit Rating
TUSTIN, Calif.--(BUSINESS WIRE)-- #Moodys--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) announced today that Moody's Ratings (“Moody's”) issued a report on October 17, 2024 affirming Sabra's Ba1 ratings and upgrading Sabra's outlook to “Positive” from “Stable”. The report credits Sabra's upgraded outlook to improving industry fundamentals for skilled nursing and senior housing, which is driving an improvement in Sabra's key credit metrics, particularly net debt to EBITDA. For additional informat.
businesswire.com
- 2 months ago
Sabra Health Care REIT, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call
TUSTIN, Calif.--(BUSINESS WIRE)-- #3Q24--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2024 third quarter earnings release on October 31, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 third quarter results will be held on Friday, November 1 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID.
businesswire.com
- 3 months ago
Sabra Health Care REIT, Inc. to Attend Fall Conferences
TUSTIN, Calif.--(BUSINESS WIRE)-- #asha--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Darrin Smith, the company's Executive Vice President of Investments, Eliza Gozar, the company's Senior Vice President of Investments, and Lauren Nisley, the company's Director of Investments, will attend the INVEST Conference on October 7-9, 2024 at the JW Marriott Dallas Arts District in Dallas, Texas. Talya Nevo-Hacohen, the company's.
businesswire.com
- 3 months ago
Sabra Health Care REIT: Turning The Corner
Sabra Healthcare REIT is showing a strong turnaround with impressive Q2 earnings, driven by increased occupancy and NOI growth, particularly in senior housing. The REIT's deleveraging efforts and strong liquidity position it well for future investments, with no debt maturing before 2026 and investment-grade ratings. Dividend growth is expected to resume in 2025, with management raising AFFO guidance, suggesting potential for share price appreciation despite lagging peers.
seekingalpha.com
- 4 months ago
8. Profile
Summary
Sabra Health Care REIT, Inc. SBRA
COUNTRY
US
INDUSTRY
REIT - Healthcare Facilities
MARKET CAP
$ 4.01 B
Dividend Yield
1.61%
Description
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.
Contact
18500 Von Karman Avenue, Irvine, CA, 92612
https://www.sabrahealth.com
IPO
Date
April 2, 2002
Employees
48
Officers
Mr. Lukas Michael Hartwich C.F.A.
Senior Vice President of Finance
Mr. Peter W. Nyland
Executive Vice President of Asset Management
Ms. Jessica Flores
Executive Vice President, Chief Accounting Officer & Principal Accounting officer
Ms. Eliza Gozar
Senior Vice President of Investments
Mr. Michael Lourenco Costa CPA
Executive Vice President, Chief Financial Officer & Secretary
Mr. Richard K. Matros
Chairman, President & Chief Executive Officer
Mr. Darrin L. Smith
Executive Vice President of Investments
Ms. Talya Nevo-Hacohen
Executive Vice President, Chief Investment Officer & Treasurer